Medscape, a well known global online platform for the medical community, has added a new CME (Continuing Medical Education) accredited activity to increase knowledge about the treatment of immune-mediated thrombotic thrombocytopenic purpura (iTTP) entitled "Advances in iTTP: How Can New Therapeutic Options Improve Patient Care?" .
The activity is intended for hematology/oncology specialists, emergency medicine physicians, and critical care specialists. It features a discussion between two members of our Medical Advisory Network, Spero Cataland MD and Marie Scully MD. Answering TTP Foundation is proud to have acted as a purely volunteer educational partner in the development of this global educational initiative.